← back to search

Xun Zhang

Qinghai University · CN
Area of research
Epidemiology · Obstetrics and Gynecology
Research interest
Research interests include Cervical Cancer and HPV Research, Endometrial and Cervical Cancer Treatments, Reproductive tract infections research, and Head and Neck Cancer Studies.
h-index
35
citations
4,258
works
196
NIH funding
primary concept
Medicine
email

Recent publications

Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial
Phytomedicine 2023cited by 16position: middledoi
Spatula: Efficient cross-camera video analytics on large camera networks
2020cited by 86position: middledoi
Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial
Cancer Medicine 2019cited by 56position: middledoi
Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China
Chinese Journal of Cancer Research 2019cited by 37position: middledoi
Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in China
The Journal of Infectious Diseases 2018cited by 22position: middledoi
Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse
Journal of Gynecologic Oncology 2017cited by 44position: middledoi
Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China
Journal of Clinical Virology 2017cited by 34position: middledoi
Association between human papillomavirus (HPV) 16, HPV18, and other HR‐HPV viral load and the histological classification of cervical lesions: Results from a large‐scale cross‐sectional study
Journal of Medical Virology 2016cited by 46position: middledoi
Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial
Cancer Medicine 2016cited by 44position: middledoi
Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China
International Journal of Cancer 2016cited by 29position: middledoi
The complex relationship between human papillomavirus and cervical adenocarcinoma
International Journal of Cancer 2015cited by 90position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

You‐Lin Qiao · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2015–2017)Wen Chen · National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital2 papers (2015–2016)Ruimei Feng · Fujian Medical University2 papers (2017–2017)Shuang Zhao · Xinjiang University2 papers (2018–2019)Xuelian Zhao · Jiangsu University2 papers (2018–2019)Jennifer S. Smith · University of Canberra2 papers (2016–2017)Shangying Hu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2018–2019)Feng Chen · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2017–2019)Qin‐Jing Pan · Southern Medical University2 papers (2016–2017) · 2 papers (2016–2017) · 1 papers (2015–2015)Jian Hu · Xijing Hospital1 papers (2023–2023)Yiqun Liao · Xiamen University1 papers (2016–2016)Yuanchao Shu · Zhejiang University1 papers (2020–2020) · 1 papers (2023–2023)David Jenkins · Manchester Academic Health Science Centre1 papers (2015–2015)Yu Ma · Xi'an University of Science and Technology1 papers (2023–2023)De'Andre Warren · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2016–2016) · 1 papers (2015–2015)Ganesh Ananthanarayanan · University of California, Berkeley1 papers (2020–2020)